To date, the clinical factors that have been associated with primary resistance are elevated levels of serum LDH [13], increased tumor burden [14], and lack of PD-L1 expression [15] but it is unclear whether these measures are surrogates for resistance or have a direct mechanistic role [16]. This evidence concerns the gene CD274 and neoplasm.